Prevalence and Factors Associated with Olfactory Dysfunction in Individuals with COVID-19 in Brazil: A Study of 20,669 Cases from 2020 to 2021
Abstract Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil. Materials and Methods: This is a prevalent study involving the confirmed cases of COVID-19 recorded i...
Saved in:
Published in | Medical principles and practice Vol. 33; no. 2; pp. 164 - 172 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
S. Karger AG
01.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil. Materials and Methods: This is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution. Results: Data from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27–46] vs. 39 [IQR 29–50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity. Conclusion: The prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity.
Highlights of the StudyThe prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021.Headache (odds ratio [OR] 1.32 and 1.22, respectively), coryza (OR 3.51 and 1.22, respectively), and taste disorders (OR 159.13 and 96.86, respectively) were associated with the presence of olfactory dysfunction. |
---|---|
AbstractList | The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil.
This is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution.
Data from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27-46] vs. 39 [IQR 29-50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity.
The prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity. Abstract Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil. Materials and Methods: This is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution. Results: Data from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27–46] vs. 39 [IQR 29–50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity. Conclusion: The prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity. Highlights of the StudyThe prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021.Headache (odds ratio [OR] 1.32 and 1.22, respectively), coryza (OR 3.51 and 1.22, respectively), and taste disorders (OR 159.13 and 96.86, respectively) were associated with the presence of olfactory dysfunction. The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil.OBJECTIVEThe aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil.This is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution.MATERIALS AND METHODSThis is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution.Data from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27-46] vs. 39 [IQR 29-50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity.RESULTSData from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27-46] vs. 39 [IQR 29-50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity.The prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity.CONCLUSIONThe prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity. Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil. Materials and Methods: This is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution. Results: Data from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27–46] vs. 39 [IQR 29–50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity. Conclusion: The prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity. Introduction On December 31, 2019, China reported cases of pneumonia of unknown etiology to the World Health Organization (WHO) [1]. [...]evidence indicates that olfactory changes can serve as a marker for disease at the onset of SARS-CoV-2 infection, providing valuable information for recommending isolation even before obtaining RT-PCR test results. Affected individuals may be exposed to hazardous substances, such as gases, smoke, and spoiled food, without being aware of it [16]. [...]depressive and anxiety disorders are associated with the reduced quality of life for affected individuals. Among individuals who reported anosmia, there was a higher proportion of females, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. |
Author | Armstrong, Anderson da Costa Bezerra-Santos, Márcio Souza, Carlos Alberto Gomes, Orlando Vieira Carmo, Rodrigo Feliciano do Nascimento, André Luis Oliveira do Faria, Luísa Robalinho de Silva Nobre, Yasmin Vitória Souza, Carlos Dornels Freire de Nicácio, Jandir Mendonça Magalhães, Amanda Júlia de Arruda |
Author_xml | – sequence: 1 givenname: Carlos Dornels Freire de surname: Souza fullname: Souza, Carlos Dornels Freire de email: *Carlos Dornels Freire de Souza, carlos.dornels@univasf.edu.br – sequence: 2 givenname: Amanda Júlia de Arruda surname: Magalhães fullname: Magalhães, Amanda Júlia de Arruda – sequence: 3 givenname: Yasmin Vitória surname: Silva Nobre fullname: Silva Nobre, Yasmin Vitória – sequence: 4 givenname: Carlos Alberto surname: Souza fullname: Souza, Carlos Alberto email: *Carlos Dornels Freire de Souza, carlos.dornels@univasf.edu.br – sequence: 5 givenname: André Luis Oliveira do surname: Nascimento fullname: Nascimento, André Luis Oliveira do – sequence: 6 givenname: Luísa Robalinho de surname: Faria fullname: Faria, Luísa Robalinho de – sequence: 7 givenname: Márcio surname: Bezerra-Santos fullname: Bezerra-Santos, Márcio – sequence: 8 givenname: Anderson da Costa surname: Armstrong fullname: Armstrong, Anderson da Costa – sequence: 9 givenname: Jandir Mendonça surname: Nicácio fullname: Nicácio, Jandir Mendonça – sequence: 10 givenname: Orlando Vieira surname: Gomes fullname: Gomes, Orlando Vieira – sequence: 11 givenname: Rodrigo Feliciano do surname: Carmo fullname: Carmo, Rodrigo Feliciano do |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38198785$$D View this record in MEDLINE/PubMed |
BookMark | eNpt0luPEyEUB3Bi1rgXffDdGBJfNHGUM8wwgy-mdl1tsqZNvLwShssu6xQqzNTUD-FnltpaL5EXCOeXP4fAKTrywRuE7gN5BlDz54SQmjLgcAudQFXSgkANR3lNAIqmbuAYnaZ0k1lLKbmDjmkLvG3a-gR9X0Szlr3xymDpNb6Qaggx4UlKQTk5GI2_uuEaz3v7s7LB55tkR68GFzx2Hs-8dmunR9mnnZzOP83OC-Db4qsov7n-BZ7g98OoNzhYXJKnjHE8lckkbGNY5p2S4CFsZ7iLbtucZO7t5zP08eL1h-nb4nL-ZjadXBaqaslQWE0J2LKqbMeMqnljeVdSzbqWdIRToksDLQWlqKnrjnWWAQPTVR01hDSK0jP0cpe7Grul0cr4IcperKJbyrgRQTrxd8W7a3EV1gKAcNZwyAmP9wkxfBlNGsTSJWX6XnoTxiTKbKo8Wp7po3_oTRijz_cTlFSsausSqqwe_tnSoZdfb5XBkx1QMaQUjT0QIGL7D8ThH_w-8rOMVyYe5LvFYifEStusHvxX7UN-AA2ztmU |
Cites_doi | 10.1016/j.bjorl.2021.04.001 10.4178/epih.e2023079 10.1111/odi.13951 10.3346/jkms.2020.35.e174 10.1111/obr.12800 10.1093/ve/veac024 10.1007/s13365-022-01060-9 10.1136/bmj-2021-069503 10.1007/s00405-020-05965-1 10.1007/s12070-021-02630-9 10.1007/s00405-021-06826-1 10.1021/acschemneuro.1c00542 10.12688/f1000research.28393.1 10.3389/fimmu.2023.1045009 10.1152/physrev.00012.2023 10.1590/1806-9282.20220078 10.36660/abc.20200209 10.1016/j.tins.2022.11.003 10.1007/s00508-020-01760-4 10.1007/s00415-010-5513-8 http://doi.org/10.1056/NEJMoa2001017 10.1016/j.cmi.2020.12.029 10.1016/j.bjorl.2020.05.008 10.1016/j.virusres.2021.198532 10.1016/j.amjoto.2020.102581 10.1016/j.bjorl.2020.12.002 10.1093/ofid/ofaa199 10.1038/s41588-021-00986-w 10.1016/j.cell.2020.06.043 10.1007/s00405-020-06496-5 10.1038/s41598-021-92775-y 10.1371/journal.pone.0256998 10.1177/0194599820925056 10.1055/s-0042-1758716 http://doi.org/10.1136/jnnp-2022-329162 10.1038/s41586-020-2012-7 10.1017/S0950268821000935 10.3389/fphys.2021.622987 10.1016/j.bjorl.2020.08.001 10.1177/0194599820965920 10.1016/j.jadr.2021.100156 10.3390/nu14061262 |
ContentType | Journal Article |
Copyright | 2024 The Author(s). Published by S. Karger AG, Basel 2024 The Author(s). Published by S. Karger AG, Basel. 2024 The Author(s). Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content 2024 The Author(s). Published by S. Karger AG, Basel 2024 |
Copyright_xml | – notice: 2024 The Author(s). Published by S. Karger AG, Basel – notice: 2024 The Author(s). Published by S. Karger AG, Basel. – notice: 2024 The Author(s). Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content – notice: 2024 The Author(s). Published by S. Karger AG, Basel 2024 |
DBID | M-- AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1159/000536191 |
DatabaseName | Karger Open Access Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest - Health & Medical Complete保健、医学与药学数据库 ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: M-- name: Karger Open Access Journals url: https://www.karger.com/OpenAccess sourceTypes: Enrichment Source Publisher – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Olfactory Dysfunction in Individuals with COVID-19 in Brazil |
EISSN | 1423-0151 |
EndPage | 172 |
ExternalDocumentID | PMC11096791 38198785 10_1159_000536191 536191 |
Genre | Journal Article |
GeographicLocations | Brazil |
GeographicLocations_xml | – name: Brazil |
GroupedDBID | --- 0R~ 0~B 30W 326 36B 3O. 3V. 4.4 53G 5GY 7X7 88E 8FI 8FJ 8UI AAWTL AAYIC ABPAZ ABUWG ACGFS ADBBV AENEX AEYAO AFKRA AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZPMC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CS3 CYUIP DU5 E0A E3Z EBS EMB EMOBN F5P FB. FYUFA GROUPED_DOAJ HMCUK HYE HZ~ IAO IHR KUZGX M-- M1P MK0 O1H O9- OK1 P2P PQQKQ PROAC PSQYO RKO RNS RPM SV3 UJ6 UKHRP AAYXX ABBTS ABWCG ACQXL ADAGL AFJJK AFSIO AHFRZ AIOBO CAG CITATION COF DIK EJD ITC PHGZM PHGZT RIG RXVBD TR2 CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c480t-fd301f244fb6ec597f9b23d6b80b0930d2e1831cc3e55b6bf6161eb4b3e007c33 |
IEDL.DBID | 7X7 |
ISSN | 1011-7571 1423-0151 |
IngestDate | Thu Aug 21 18:35:34 EDT 2025 Thu Jul 10 18:32:36 EDT 2025 Fri Jul 25 06:48:55 EDT 2025 Sat May 10 01:40:50 EDT 2025 Tue Jul 01 05:09:30 EDT 2025 Thu Aug 29 12:04:27 EDT 2024 Sat Aug 31 21:00:32 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | COVID-19 SARS-CoV-2 Symptoms Smell |
Language | English |
License | This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. https://creativecommons.org/licenses/by-nc/4.0 2024 The Author(s). Published by S. Karger AG, Basel. This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c480t-fd301f244fb6ec597f9b23d6b80b0930d2e1831cc3e55b6bf6161eb4b3e007c33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://karger.com/doi/10.1159/000536191 |
PMID | 38198785 |
PQID | 3046485214 |
PQPubID | 2047984 |
PageCount | 9 |
ParticipantIDs | pubmed_primary_38198785 proquest_journals_3046485214 proquest_miscellaneous_2913444489 crossref_primary_10_1159_000536191 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11096791 karger_primary_536191 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-04-01 |
PublicationDateYYYYMMDD | 2024-04-01 |
PublicationDate_xml | – month: 04 year: 2024 text: 2024-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Basel |
PublicationTitle | Medical principles and practice |
PublicationTitleAlternate | Med Princ Pract |
PublicationYear | 2024 |
Publisher | S. Karger AG |
Publisher_xml | – name: S. Karger AG |
References | Hojo-Souza NS, Freitas VLS, Guidoni DL, Souza FSH. Clinical symptom profile of hospitalized COVID-19 Brazilian patients according to SARS-CoV-2 variants. Epidemiol Health. 2023;45:e2023079–2023. . Velluzzi F, Deledda A, Onida M, Loviselli A, Crnjar R, Sollai G. Relationship between olfactory function and BMI in normal weight healthy subjects and patients with overweight or obesity. Nutrients. 2022;14(6):1262. . Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, . A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. . Chen S, Wang S. The immune mechanism of the nasal epithelium in COVID-19-related olfactory dysfunction. Front Immunol. 2023;14:1045009. . Shelton JF, Shastri AJ, Fletez-Brant K, Aslibekyan S, Auton A; 23andMe COVID-19 Team. The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nat Genet. 2022;54(2):121–4. . Ahmed AK, Sayad R, Mahmoud IA, EL-Monem AMA, Badry SH, Ibrahim IH, . “Anosmia” the mysterious collateral damage of COVID-19. J Neurovirol. 2022;28(2):189–200. . Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngol. 2020;277(8):2251–61. . Gamerra M, de Corso E, Cantone E. COVID-19: the crucial role of the nose. Braz J Otorhinolaryngol. 2021;87(1):118–9. . von Bartheld CS, Hagen MM, Butowt R. The D614G virus mutation enhances anosmia in COVID-19 patients: evidence from a systematic review and meta-analysis of studies from South Asia. ACS Chem Neurosci. 2021;12(19):3535–49. . Terças-Trettel ACP, Muraro AP, Andrade ACd S, Oliveira EC. Self-reported symptoms and seroprevalence against SARS-CoV-2 in the population of Mato Grosso: a household-based survey in 2020. Rev Assoc Med Bras. 2022;68(7):928–34. . Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. . Lima MHLC, Cavalcante ALB, Leão SC. Pathophysiological relationship between COVID-19 and olfactory dysfunction: a systematic review. Braz J Otorhinolaryngol. 2021. . Vestito L, Mori L, Trompetto C, Bagnasco D, Canevari RF, Ponzano M, . Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled study. J Neurol Neurosurg Psychiatry. 2023;94(1):87–8. . Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581. . Costa KVTda, Carnaúba ATL, Rocha KW, Andrade KCLde, Ferreira SMS, Menezes Pd L. Olfactory and taste disorders in COVID-19: a systematic review. Braz J Otorhinolaryngol. 2020;86(6):781–92. . Burges Watson DL, Campbell M, Hopkins C, Smith B, Kelly C, Deary V. Altered smell and taste: anosmia, parosmia and the impact of long Covid-19. PLoS One. 2021;16(9):e0256998. . Giovanetti M, Fonseca V, Wilkinson E, Tegally H, San EJ, Althaus CL, . Replacement of the Gamma by the Delta variant in Brazil: impact of lineage displacement on the ongoing pandemic. Virus Evol. 2022;8(1):veac024–6. . Silva FTD, Sperandio M, Suzuki SS, Silva HPV, de Oliveira DG, Stefenon L, . Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil. Oral Dis. 2022;28(Suppl 2):2559–62. . Feehan AK, Fort D, Velasco C, Burton JH, Garcia-Diaz J, Price-Haywood EG, . The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study. Clin Microbiol Infect. 2021;27(4):633.e9–16. . Yom-Tov E, Lekkas D, Jacobson NC. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation. J Affect Disord. 2021;5:100156. . Altundag A, Saatci O, Sanli DET, Duz OA, Sanli AN, Olmuscelik O, . The temporal course of COVID-19 anosmia and relation to other clinical symptoms. Eur Arch Oto-Rhino-Laryngol. 2021;278(6):1891–7. . Franceschi VB, Ferrareze PAG, Zimerman RA, Cybis GB, Thompson CE. Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021. Virus Res. 2021;304:198532. . Strabelli TMV, Uip DE. COVID-19 and the heart. Arq Bras Cardiol. 2020;114(4):598–600. . Mutiawati E, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Maliga HA, . Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis. F1000Res. 2021;10:40. . Tan BKJ, Han R, Zhao JJ, Tan NKW, Quah ESH, Tan CJ, . Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. . Peng M, Coutts D, Wang T, Cakmak YO. Systematic review of olfactory shifts related to obesity. Obes Rev. 2019;20(2):325–38. . Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, . Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–27.e19. . Hendawy E, El-Anwar MW, Elghamry RM, Abdallah AM, Ibrahim AM. Anosmia in COVID-19 patients: can we predict the severity of chest manifestations. Int Arch Otorhinolaryngol. 2023;27(1):e143–1. . Tsukahara T, Brann DH, Datta SR. Mechanisms of SARS-CoV-2-associated anosmia. Physiol Rev. 2023;103(4):2759–66. . Mendonça CV, Mendes Neto JA, Suzuki FA, Orth MS, Machado Neto H, Nacif SR. Disfunção de olfato na Covid-19: marcador de bom prognóstico. Braz J Otorhinolaryngol. 2022;88(3):439–44. . Instituto Brasileiro de Geografia e Estatística. Dados demográficos. Bahia. 2023. Available from: https://www.ibge.gov.br/cidades-e-estados/ba.html. Karimi-Galougahi M, Raad N, Mikaniki N. Anosmia and the need for COVID-19 screening during the pandemic. Otolaryngol Head Neck Surg. 2020;163(1):96–97. . Mutiawati E, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Maliga HA, . Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms: a systematic review and meta-analysis. F1000Res. 2021;10:40. Lee Y, Min P, Lee S, Kim S-W. Prevalence and duration of Acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020;35(18):e174. . Rashid RA, Alaqeedy AA, Al-Ani RM. Parosmia due to COVID-19 disease: a 268 case series. Indian J Otolaryngol Head Neck Surg. 2021;74(Suppl 2):2970–7. . Chung TW, Sridhar S, Zhang AJ, Chan KH, Li HL, Wong FK, . Olfactory dysfunction in Coronavirus disease 2019 patients: observational cohort study and systematic review. Open Forum Infect Dis. 2020;7(6):ofaa199. . Altundag A, Yıldırım D, Tekcan Sanli DE, Cayonu M, Kandemirli SG, Sanli AN, . Olfactory cleft measurements and COVID-19–related anosmia. Otolaryngol Head Neck Surg. 2021;164(6):1337–44. . Butowt R, Bilinska K, von Bartheld CS. Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci. 2023;46(1):75–90. . Prem B, Liu DT, Besser G, Renner B, Mueller CA. Retronasal olfactory testing in early diagnosed and suspected COVID-19 patients: a 7-week follow-up study. Eur Arch Oto-Rhino-Laryngol. 2022;279(1):257–65. . Menezes AMB, Victora CG, Hartwig FP, Silveira MF, Horta BL, Barros AJD, . High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2. Sci Rep. 2021;11(1):13279. . Landis BN, Scheibe M, Weber C, Berger R, Brämerson A, Bende M, . Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol. 2010;257(8):1303–8. . Baggio JAO, Machado MF, do CRF, Armstrong Ada C, Santos ADdos, Souza CDFde. COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality–a retrospective study with data from 59,695 individuals. Epidemiol Infect. 2021:149. . World Health Organization (WHO). Coronavirus disease 2019 (COVID-19): situation report - 51. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 (accessed Sep 10, 2022). Sbrana MF, Fornazieri MA, Bruni-Cardoso A, Avelino-Silva VI, Schechtman D, Voegels RL, . Olfactory dysfunction in frontline health care professionals during COVID-19 pandemic in Brazil. Front Physiol. 2021;12:622987. . Secretaria de Saúde (Bahia). Núcleos Regionais de Saúde: regiões de Saúde do Estado da Bahia. 2022. Available from: http://www1.saude.ba.gov.br/mapa_bahia/VISAOMACRORREGIAOch.asp. Mesquita RR, Silva LCF, Santana FMS, Oliveira TF, Alcântara RC, Arnozo G, . Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2020;133(7-8):377–382. . ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref42 ref41 ref22 ref21 ref43 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 |
References_xml | – reference: Peng M, Coutts D, Wang T, Cakmak YO. Systematic review of olfactory shifts related to obesity. Obes Rev. 2019;20(2):325–38. . – reference: Secretaria de Saúde (Bahia). Núcleos Regionais de Saúde: regiões de Saúde do Estado da Bahia. 2022. Available from: http://www1.saude.ba.gov.br/mapa_bahia/VISAOMACRORREGIAOch.asp. – reference: Franceschi VB, Ferrareze PAG, Zimerman RA, Cybis GB, Thompson CE. Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021. Virus Res. 2021;304:198532. . – reference: Butowt R, Bilinska K, von Bartheld CS. Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci. 2023;46(1):75–90. . – reference: Costa KVTda, Carnaúba ATL, Rocha KW, Andrade KCLde, Ferreira SMS, Menezes Pd L. Olfactory and taste disorders in COVID-19: a systematic review. Braz J Otorhinolaryngol. 2020;86(6):781–92. . – reference: Menezes AMB, Victora CG, Hartwig FP, Silveira MF, Horta BL, Barros AJD, . High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2. Sci Rep. 2021;11(1):13279. . – reference: Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngol. 2020;277(8):2251–61. . – reference: Yom-Tov E, Lekkas D, Jacobson NC. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation. J Affect Disord. 2021;5:100156. . – reference: von Bartheld CS, Hagen MM, Butowt R. The D614G virus mutation enhances anosmia in COVID-19 patients: evidence from a systematic review and meta-analysis of studies from South Asia. ACS Chem Neurosci. 2021;12(19):3535–49. . – reference: Hendawy E, El-Anwar MW, Elghamry RM, Abdallah AM, Ibrahim AM. Anosmia in COVID-19 patients: can we predict the severity of chest manifestations. Int Arch Otorhinolaryngol. 2023;27(1):e143–1. . – reference: Rashid RA, Alaqeedy AA, Al-Ani RM. Parosmia due to COVID-19 disease: a 268 case series. Indian J Otolaryngol Head Neck Surg. 2021;74(Suppl 2):2970–7. . – reference: Mutiawati E, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Maliga HA, . Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms: a systematic review and meta-analysis. F1000Res. 2021;10:40. – reference: Ahmed AK, Sayad R, Mahmoud IA, EL-Monem AMA, Badry SH, Ibrahim IH, . “Anosmia” the mysterious collateral damage of COVID-19. J Neurovirol. 2022;28(2):189–200. . – reference: Altundag A, Yıldırım D, Tekcan Sanli DE, Cayonu M, Kandemirli SG, Sanli AN, . Olfactory cleft measurements and COVID-19–related anosmia. Otolaryngol Head Neck Surg. 2021;164(6):1337–44. . – reference: Mutiawati E, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Maliga HA, . Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis. F1000Res. 2021;10:40. . – reference: Shelton JF, Shastri AJ, Fletez-Brant K, Aslibekyan S, Auton A; 23andMe COVID-19 Team. The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nat Genet. 2022;54(2):121–4. . – reference: Gamerra M, de Corso E, Cantone E. COVID-19: the crucial role of the nose. Braz J Otorhinolaryngol. 2021;87(1):118–9. . – reference: Sbrana MF, Fornazieri MA, Bruni-Cardoso A, Avelino-Silva VI, Schechtman D, Voegels RL, . Olfactory dysfunction in frontline health care professionals during COVID-19 pandemic in Brazil. Front Physiol. 2021;12:622987. . – reference: Feehan AK, Fort D, Velasco C, Burton JH, Garcia-Diaz J, Price-Haywood EG, . The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study. Clin Microbiol Infect. 2021;27(4):633.e9–16. . – reference: Chung TW, Sridhar S, Zhang AJ, Chan KH, Li HL, Wong FK, . Olfactory dysfunction in Coronavirus disease 2019 patients: observational cohort study and systematic review. Open Forum Infect Dis. 2020;7(6):ofaa199. . – reference: Strabelli TMV, Uip DE. COVID-19 and the heart. Arq Bras Cardiol. 2020;114(4):598–600. . – reference: Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. . – reference: Chen S, Wang S. The immune mechanism of the nasal epithelium in COVID-19-related olfactory dysfunction. Front Immunol. 2023;14:1045009. . – reference: Hojo-Souza NS, Freitas VLS, Guidoni DL, Souza FSH. Clinical symptom profile of hospitalized COVID-19 Brazilian patients according to SARS-CoV-2 variants. Epidemiol Health. 2023;45:e2023079–2023. . – reference: Silva FTD, Sperandio M, Suzuki SS, Silva HPV, de Oliveira DG, Stefenon L, . Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil. Oral Dis. 2022;28(Suppl 2):2559–62. . – reference: Terças-Trettel ACP, Muraro AP, Andrade ACd S, Oliveira EC. Self-reported symptoms and seroprevalence against SARS-CoV-2 in the population of Mato Grosso: a household-based survey in 2020. Rev Assoc Med Bras. 2022;68(7):928–34. . – reference: Lima MHLC, Cavalcante ALB, Leão SC. Pathophysiological relationship between COVID-19 and olfactory dysfunction: a systematic review. Braz J Otorhinolaryngol. 2021. . – reference: Mendonça CV, Mendes Neto JA, Suzuki FA, Orth MS, Machado Neto H, Nacif SR. Disfunção de olfato na Covid-19: marcador de bom prognóstico. Braz J Otorhinolaryngol. 2022;88(3):439–44. . – reference: Landis BN, Scheibe M, Weber C, Berger R, Brämerson A, Bende M, . Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol. 2010;257(8):1303–8. . – reference: World Health Organization (WHO). Coronavirus disease 2019 (COVID-19): situation report - 51. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 (accessed Sep 10, 2022). – reference: Altundag A, Saatci O, Sanli DET, Duz OA, Sanli AN, Olmuscelik O, . The temporal course of COVID-19 anosmia and relation to other clinical symptoms. Eur Arch Oto-Rhino-Laryngol. 2021;278(6):1891–7. . – reference: Burges Watson DL, Campbell M, Hopkins C, Smith B, Kelly C, Deary V. Altered smell and taste: anosmia, parosmia and the impact of long Covid-19. PLoS One. 2021;16(9):e0256998. . – reference: Baggio JAO, Machado MF, do CRF, Armstrong Ada C, Santos ADdos, Souza CDFde. COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality–a retrospective study with data from 59,695 individuals. Epidemiol Infect. 2021:149. . – reference: Instituto Brasileiro de Geografia e Estatística. Dados demográficos. Bahia. 2023. Available from: https://www.ibge.gov.br/cidades-e-estados/ba.html. – reference: Velluzzi F, Deledda A, Onida M, Loviselli A, Crnjar R, Sollai G. Relationship between olfactory function and BMI in normal weight healthy subjects and patients with overweight or obesity. Nutrients. 2022;14(6):1262. . – reference: Tan BKJ, Han R, Zhao JJ, Tan NKW, Quah ESH, Tan CJ, . Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. . – reference: Karimi-Galougahi M, Raad N, Mikaniki N. Anosmia and the need for COVID-19 screening during the pandemic. Otolaryngol Head Neck Surg. 2020;163(1):96–97. . – reference: Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581. . – reference: Prem B, Liu DT, Besser G, Renner B, Mueller CA. Retronasal olfactory testing in early diagnosed and suspected COVID-19 patients: a 7-week follow-up study. Eur Arch Oto-Rhino-Laryngol. 2022;279(1):257–65. . – reference: Vestito L, Mori L, Trompetto C, Bagnasco D, Canevari RF, Ponzano M, . Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled study. J Neurol Neurosurg Psychiatry. 2023;94(1):87–8. . – reference: Mesquita RR, Silva LCF, Santana FMS, Oliveira TF, Alcântara RC, Arnozo G, . Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2020;133(7-8):377–382. . – reference: Giovanetti M, Fonseca V, Wilkinson E, Tegally H, San EJ, Althaus CL, . Replacement of the Gamma by the Delta variant in Brazil: impact of lineage displacement on the ongoing pandemic. Virus Evol. 2022;8(1):veac024–6. . – reference: Lee Y, Min P, Lee S, Kim S-W. Prevalence and duration of Acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020;35(18):e174. . – reference: Tsukahara T, Brann DH, Datta SR. Mechanisms of SARS-CoV-2-associated anosmia. Physiol Rev. 2023;103(4):2759–66. . – reference: Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, . A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. . – reference: Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, . Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–27.e19. . – ident: ref12 doi: 10.1016/j.bjorl.2021.04.001 – ident: ref18 doi: 10.4178/epih.e2023079 – ident: ref21 doi: 10.1111/odi.13951 – ident: ref37 doi: 10.3346/jkms.2020.35.e174 – ident: ref23 doi: 10.1111/obr.12800 – ident: ref31 doi: 10.1093/ve/veac024 – ident: ref11 doi: 10.1007/s13365-022-01060-9 – ident: ref14 doi: 10.1136/bmj-2021-069503 – ident: ref6 doi: 10.1007/s00405-020-05965-1 – ident: ref9 doi: 10.1007/s12070-021-02630-9 – ident: ref39 doi: 10.1007/s00405-021-06826-1 – ident: ref29 doi: 10.1021/acschemneuro.1c00542 – ident: ref32 doi: 10.12688/f1000research.28393.1 – ident: ref41 doi: 10.3389/fimmu.2023.1045009 – ident: ref34 doi: 10.1152/physrev.00012.2023 – ident: ref22 doi: 10.1590/1806-9282.20220078 – ident: ref2 doi: 10.36660/abc.20200209 – ident: ref33 doi: 10.1016/j.tins.2022.11.003 – ident: ref4 doi: 10.1007/s00508-020-01760-4 – ident: ref36 doi: 10.1007/s00415-010-5513-8 – ident: ref1 doi: http://doi.org/10.1056/NEJMoa2001017 – ident: ref38 doi: 10.1016/j.cmi.2020.12.029 – ident: ref40 doi: 10.1016/j.bjorl.2020.05.008 – ident: ref30 doi: 10.1016/j.virusres.2021.198532 – ident: ref35 doi: 10.1016/j.amjoto.2020.102581 – ident: ref24 doi: 10.1016/j.bjorl.2020.12.002 – ident: ref26 doi: 10.1093/ofid/ofaa199 – ident: ref25 doi: 10.12688/f1000research.28393.1 – ident: ref27 doi: 10.1038/s41588-021-00986-w – ident: ref28 doi: 10.1016/j.cell.2020.06.043 – ident: ref13 doi: 10.1007/s00405-020-06496-5 – ident: ref19 doi: 10.1038/s41598-021-92775-y – ident: ref15 doi: 10.1371/journal.pone.0256998 – ident: ref7 doi: 10.1177/0194599820925056 – ident: ref42 doi: 10.1055/s-0042-1758716 – ident: ref17 doi: http://doi.org/10.1136/jnnp-2022-329162 – ident: ref3 doi: 10.1038/s41586-020-2012-7 – ident: ref5 doi: 10.1017/S0950268821000935 – ident: ref20 doi: 10.3389/fphys.2021.622987 – ident: ref8 doi: 10.1016/j.bjorl.2020.08.001 – ident: ref10 doi: 10.1177/0194599820965920 – ident: ref16 doi: 10.1016/j.jadr.2021.100156 – ident: ref43 doi: 10.3390/nu14061262 |
SSID | ssj0008330 |
Score | 2.3246658 |
Snippet | Abstract
Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the... Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2... The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the... Introduction On December 31, 2019, China reported cases of pneumonia of unknown etiology to the World Health Organization (WHO) [1]. [...]evidence indicates... |
SourceID | pubmedcentral proquest pubmed crossref karger |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 164 |
SubjectTerms | Adolescent Adult Age Aged Brazil - epidemiology Child Comorbidity COVID-19 - complications COVID-19 - epidemiology COVID-19 vaccines Disease transmission Female Females Gender Humans Immunization Male Middle Aged Olfaction disorders Olfaction Disorders - epidemiology Olfaction Disorders - etiology Original Paper Pandemics Pneumonia Prevalence Professionals Risk Factors SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Young Adult |
SummonAdditionalLinks | – databaseName: Karger Open Access Journals dbid: M-- link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwELZQQVUviEeBQEEGccSSH4ljcytbVi3S0h4o6i2KY1tdUWWrZntYfgS_mZk4iboV5BLJ4yiKZyYzY898Q8hHRMnS2kUmjNUsl7FhRmAGQOR18LUuXQ-ltPiuj8_zbxfFxbDfgbUwvzD_uYdGnbAFwOD2recU-PoQ5zyEOEohSv6Csemfa5RKuANCsLIoxYAhtPXoHtnF8MSU2Df5jhF6lN75LxfzfqbkHdMzf0IeDz4jPUxMfkoehPYZ2V0Mp-LPyR_EYar76iFat57OUw8dOi598BS3W-npVequs6FHmw4NGjKFLlt6MlVldWnm7PTnyRETFolfburfy6vP9JBizuGGriKV_JPWls7AAnYUC1RgRHK6XuFd7JPz-dcfs2M29FlgTW74mkUPWh7BzkenQwMRRrROKq-d4Y5bxb0MoPiiaVQoCgeM1eAmBpc7FcDDaJR6QXbaVRteERokD9wrH30D5jHPrfIBG6O62BSyMTIjH8aFr64TnEbVhyGFrSZGZWQ_sWSaMo4f3BtfnJ0lUnXtI5BHBlaDInYVHvyCOEqRZ-T9RAYVwnORug2r266SmH0Al7EZeZn4Pb1hlJiMmC1JmCYgPPc2pV1e9jDdiOWqSyte_-dz3pA9YMqQBnRAdtY3t-EteDhr964X7r8zx_Gc priority: 102 providerName: Karger AG |
Title | Prevalence and Factors Associated with Olfactory Dysfunction in Individuals with COVID-19 in Brazil: A Study of 20,669 Cases from 2020 to 2021 |
URI | https://karger.com/doi/10.1159/000536191 https://www.ncbi.nlm.nih.gov/pubmed/38198785 https://www.proquest.com/docview/3046485214 https://www.proquest.com/docview/2913444489 https://pubmed.ncbi.nlm.nih.gov/PMC11096791 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgQ4iXiY8xAqMyiEcsYjtxEl7Q1q3akLpViKG-RfGXqJiS0nQP3R_B38xdvqATog-p5LOSKD_bd-c7_46Qd8iSpZT2jKeZYpHwhqUcMwB8WDhbqEQ3VErTC3V2FX2ex_Nuw63u0ir7NbFZqG1lcI_8A0bw4L6CR5-WPxlWjcLoaldC4z7ZReoyTOlK5oPDBdaFbNkIOGdJnPCOWQg0eFPLToLzwLf00YMfmH69-pe1eTdp8i8tNHlM9jrzkR61eD8h91z5lDycdgHyZ-QXUjIVzUEiWpSWTtpyOrRHwVmKO6_08rottLOhJ5sadRviQxclPR8OaNVtz_Hlt_MTxjMUHq-K28X1R3pEMf1wQytPRfheqYyOQRnWFM-qQIsI6brCf75PrianX8dnrCu5wEyUhmvmLUx4Dyrfa-UMOBs-00JapdNQh5kMrXCwBnBjpItjDRgrsBidjrR0YGwYKZ-TnbIq3QtCnQhdaKX11oCmjKJMWoc1UrU3sTCpCMjb_sPny5ZZI288kjjLB3QCst9CMnTp2w_vtE9ns1aUL60HcQ9g3s3JOv8zggLyZhDDbMIQSVG66qbOBSYiwC_NAnLQ4j08AX3bNEnjgKRbI2HogEzd25Jy8b1h7EZaV5Vk_OX_3-sVeQTYdIlBh2Rnvbpxr8HmWetRM7BHZPf49GL2ZdTsHMB1ythvvBoAZw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemDgEviI8BgQEGwRsRsZM4CRJCW7uqZWtXoQ3tLcSxLSqmpDSdUPkj-FP4G7mLk0AnxNvyEsln5esu9-E7_46Ql4iSJYQ0LosT4Qbc5G7MsALAeJlWmYhkDaU0mYrRafDhLDzbIr_avTBYVtnqxFpRqzLHNfI3mMGD63IWvF98c7FrFGZX2xYaViwO9fo7hGzVu_EA-PuK8-HBSX_kNl0F3DyIvZVrFMi0AatmpNA5-NMmkdxXQsaehPDeU1yDmLM893UYSngNAU6RloH0NdjTHBdAQeVvBz6EMj2yvX8wnX3sdH_s-xb_gDE3CiPWYBmBz1B3z_MhXGEbFvDaVyz4Xv7Lv71cpvmX3RveJrcah5XuWQm7Q7Z0cZdcnzQp-XvkJ4JAZfXWJZoVig5tAx_a8l0rimu99PjctvZZ08G6QmuKEkHnBR13W8IqO7N__Gk8cFmCxP1l9mN-_pbuUSx4XNPSUO69FiKhfTC_FcXdMTDCPboq8cx2yOmVsOM-6RVloR8SqrmnPeUro3KwzUGQ-EpjV1Zp8pDnMXfIi_bDpwuL5ZHWMVCYpB13HLJjWdJNacd3L41PZjNLShfKALllYNpogSr9I7MOed6R4f_FpExW6PKiSjmWPsARJw55YPnd3QGj6TiKQ4fEG5LQTUBs8E1KMf9SY4QjkKyIEvbo_8_1jNwYnUyO0qPx9PAxuQl8asqSdklvtbzQT8DjWsmnjZhT8vmq_6zftCQ7TQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELemgSZeEH8GBAYYBG9Ei53ESZAQGi3VyujWB4b6lsX_RMWUlKYTKh-CD8Sn4y5OAp0Qb-tLJJ-VJrmffXf2-XeEvECWLCGk9VmaCT_iVvkpwwwAGxRGFyKRDZXS5FgcnkYfZvFsi_zqzsJgWmU3JzYTta4UrpHv4w4e3JezaN-2aRHT4ejt4puPFaRwp7Urp-EgcmTW3yF8q9-Mh6Drl5yP3n8aHPpthQFfRWmw8q0GfFuwcFYKo8C3tpnkoRYyDSSE-oHmBiDPlApNHEt4JQEOkpGRDA3YVoWLoTD9X0vCmOEYS2Z9sAeeTeiYEBjzkzhhLasReA9NHb0QAhe2YQuvf8XU7-W_PN3LCZt_WcDRLXKzdV3pgcPabbJlyjtkZ9Juzt8lP5EOqmgOMdGi1HTkSvnQDgFGU1z1pSfnrsjPmg7XNdpVxAadl3TcHw6rXc_Byefx0GcZCt8tix_z89f0gGLq45pWlvLglRAZHYAhrimek4EWHtBVhVe2S06vRBn3yHZZleYBoYYHJtChtlqBlY6iLNQG67NKq2KuUu6R592HzxeO1SNvoqE4y3vteGTXqaTv0rXvXWqfTKdOlC-0BXGnwLydD-r8D3o98qwXw0jG7ZmiNNVFnXNMgoBfmnnkvtN3_w8YV6dJGnsk3UBC3wFZwjcl5fxLwxaOlLIiydjD_z_XU7ID4yn_OD4-ekRugJra_KQ9sr1aXpjH4Hqt5JMG45ScXfWg-g0Gpj4d |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+Factors+Associated+with+Olfactory+Dysfunction+in+Individuals+with+COVID-19+in+Brazil%3A+A+Study+of+20%2C669+Cases+from+2020+to+2021&rft.jtitle=Medical+principles+and+practice&rft.au=Souza%2C+Carlos+Dornels+Freire+de&rft.au=Magalh%C3%A3es%2C+Amanda+J%C3%BAlia+de+Arruda&rft.au=Silva+Nobre%2C+Yasmin+Vit%C3%B3ria&rft.au=Souza%2C+Carlos+Alberto&rft.date=2024-04-01&rft.issn=1011-7571&rft.eissn=1423-0151&rft.volume=33&rft.issue=2&rft.spage=164&rft.epage=172&rft_id=info:doi/10.1159%2F000536191&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000536191 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-7571&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-7571&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-7571&client=summon |